{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:28:52Z","timestamp":1783074532134,"version":"3.54.6"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139017","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T18:37:16Z","timestamp":1443206236000},"page":"e0139017","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Neesha","family":"Rockwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila H.","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation. Multidrug-resistant tuberculosis (MDR-TB) 2013 Update. 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/challenges\/mdr\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/challenges\/mdr\/en\/<\/ext-link>. Updated 2013. Accessed January\/20, 2015."},{"issue":"9728","key":"ref2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis","volume":"375","author":"NR Gandhi","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AEM.20.5.810-814.1970","article-title":"Probability distribution of drug-resistant mutants in unselected populations of <italic>Mycobacterium tuberculosis<\/italic>","volume":"20","author":"HL David","year":"1970","journal-title":"Appl. Microbiol."},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/infdis\/jir658","article-title":"Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability","volume":"204","author":"S Srivastava","year":"2011","journal-title":"J Infect Dis"},{"issue":"12","key":"ref5","first-page":"1143","article-title":"AIDS and TB drug absorption","volume":"3","author":"CA Peloquin","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tig.2012.11.005","article-title":"The heterogeneous evolution of multidrug-resistant <italic>Mycobacterium tuberculosis<\/italic>. <italic>Trends Genet<\/italic>","volume":"29","author":"B Muller","year":"2013","journal-title":"TIG"},{"key":"ref7","unstructured":"Critical Appraisal Skills Programme. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sph.nhs.uk\/what-we-do\/public-healthworkforce\/\" xlink:type=\"simple\">http:\/\/www.sph.nhs.uk\/what-we-do\/public-healthworkforce\/<\/ext-link>"},{"issue":"9167","key":"ref8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(98)11467-8","article-title":"Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium","volume":"353","author":"A Vernon","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1164\/rccm.200503-417OC","article-title":"Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis","volume":"173","author":"W Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.200903-0439OC","article-title":"Efficacy of a 6-month versus 9-month Intermittent Treatment Regimen in HIV-infected Patients with Tuberculosis A Randomized Clinical Trial","volume":"181","author":"S Swaminathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"e7954","DOI":"10.1371\/journal.pone.0007954","article-title":"Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis","volume":"4","author":"F Matthys","year":"2009","journal-title":"PloS One"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/ajrccm\/143.2.262","article-title":"A Controlled Clinical Comparison of 6 and 8 Months of Antituberculosis Chemotherapy in the Treatment of Patients with Silicotuberculosis in Hong Kong","volume":"143","year":"1991","journal-title":"Am Rev Resp Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2334-8-6","article-title":"Treatment of isoniazid-resistant pulmonary tuberculosis","volume":"8","author":"YH Kim","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/592252","article-title":"Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda","volume":"47","author":"B Temple","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref15","first-page":"31","article-title":"Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes","volume":"8","author":"T Yoshiyama","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0041-3879(91)90034-P","article-title":"Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens at 28 and 36 weeks duration in Algeria","volume":"72","year":"1991","journal-title":"Tubercle"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jama.2011.436","article-title":"Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial","volume":"305","author":"C Lienhardt","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"ref18","first-page":"509","article-title":"A controlled clinical trial of oral short course regimens in the treatment of sputum positive pulmonary tuberculosis","volume":"1","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5588\/ijtld.11.0216","article-title":"Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout","volume":"16","author":"KJM Aung","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/517536","article-title":"Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance","volume":"44","author":"HS Cox","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jinf.2005.10.002","article-title":"Drug-resistant tuberculosis: a disease of target populations in Houston, Texas","volume":"53","author":"HM El Sahly","year":"2006","journal-title":"J Infect"},{"issue":"4","key":"ref22","first-page":"381","article-title":"Drug-resistant pulmonary tuberculosis in a cohort of southern African goldminers with a high prevalence of HIV infection","volume":"90","author":"J Murray","year":"2000","journal-title":"S Afr Med J"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/381675","article-title":"Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use","volume":"38","author":"RE Nettles","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/infdis\/jit352","article-title":"Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes","volume":"208","author":"JG Pasipanodya","year":"2013","journal-title":"J Infect Dis"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/jac\/dkt103","article-title":"Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan","volume":"68","author":"JY Chien","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/323784","article-title":"Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City","volume":"33","author":"CR Driver","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2471\/BLT.06.038331","article-title":"Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance","volume":"85","author":"IY Gelmanova","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.200401-095OC","article-title":"Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy","volume":"170","author":"RM Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/430377","article-title":"Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997\u20132000","volume":"41","author":"J Li","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref30","first-page":"743","article-title":"Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin","volume":"8","author":"TS Moulding","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/cid\/cis989","article-title":"Anti-tuberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994\u20132006","volume":"56","author":"TC Porco","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref32","first-page":"631","article-title":"Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?","volume":"7","author":"HT Quy","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/425005","article-title":"The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis","volume":"39","author":"KJ Seung","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00002030-199802000-00009","article-title":"A survey of drug-resistant <italic>Mycobacterium tuberculosis<\/italic> and its relationship to HIV infection","volume":"12","author":"CW Spellman","year":"1998","journal-title":"AIDS"},{"issue":"17","key":"ref35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM199404283301702","article-title":"The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis","volume":"330","author":"SE Weis","year":"1994","journal-title":"N Engl J Med"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e83006","DOI":"10.1371\/journal.pone.0083006","article-title":"3871645; Association between <italic>Mycobacterium tuberculosis<\/italic> Complex Phylogenetic Lineage and Acquired Drug Resistance","volume":"8","author":"CM Yuen","year":"2013","journal-title":"PLoS One"},{"issue":"9032","key":"ref37","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(96)03027-9","article-title":"The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA","volume":"348","author":"WZ Bradford","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/516146","article-title":"Rifampin-monoresistant tuberculosis in New York City, 1993\u20131994","volume":"25","author":"SS Munsiff","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/429321","article-title":"Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis","volume":"40","author":"M Weiner","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","article-title":"Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis","volume":"149","author":"W Lew","year":"2008","journal-title":"Ann Intern Med"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","article-title":"Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: A systematic review and meta-analysis","volume":"6","author":"D Menzies","year":"2009","journal-title":"PLoS Med"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/cir406","article-title":"Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa","volume":"53","author":"KR Jacobson","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","article-title":"Whole-genome sequencing of rifampicin-resistant <italic>Mycobacterium tuberculosis<\/italic> strains identifies compensatory mutations in RNA polymerase genes","volume":"44","author":"I Comas","year":"2011","journal-title":"Nature Genetics"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"e1003318","DOI":"10.1371\/journal.pgen.1003318","article-title":"HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis","volume":"9","author":"L Fenner","year":"2013","journal-title":"PLoS Genetics"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/JCM.01938-07","article-title":"Spread of a low-fitness drug-resistant <italic>Mycobacterium tuberculosis<\/italic> strain in a setting of high human immunodeficiency virus prevalence","volume":"46","author":"OJ Strauss","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/599040","article-title":"Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana","volume":"48","author":"S Chideya","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent <italic>Mycobacterium tuberculosis<\/italic> killing and prevention of resistance by rifampin","volume":"51","author":"T Gumbo","year":"2007","journal-title":"Antimicrob Agents and Chemother"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00749-10","article-title":"An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future","volume":"55","author":"J Pasipanodya","year":"2011","journal-title":"Antimicrob Agents and Chemother"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","volume":"55","author":"JG Pasipanodya","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ng.2656","article-title":"<italic>Mycobacterium tuberculosis<\/italic> mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis","volume":"45","author":"CB Ford","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1469-0691.2011.03556.x","article-title":"Strain diversity, epistasis and the evolution of drug resistance in <italic>Mycobacterium tuberculosis<\/italic>","volume":"17","author":"S Borrell","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/cit167","article-title":"A meta-analysis of self-administered versus directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients","volume":"57","author":"JG Pasipanodya","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7626","key":"ref53","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"JP Ioannidis","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"e69930","DOI":"10.1371\/journal.pone.0069930","article-title":"A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses","volume":"8","author":"E Kontopantelis","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00180612","article-title":"Fixed dose combination anti-tuberculosis therapy: a systematic review and meta-analysis","volume":"42","author":"AS Albanna","year":"2013","journal-title":"Eur Resp J"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"e1000146","DOI":"10.1371\/journal.pmed.1000146","article-title":"Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis","volume":"6","author":"D Menzies","year":"2009","journal-title":"PLoS Med"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0142276","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T19:50:53Z","timestamp":1599594653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139017"}},"subtitle":[],"editor":[{"given":"Dipankar","family":"Chatterji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139017","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0142276","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}